Science Corruption Media Articles
Top leaders in the field of medicine and science have spoken out about the rampant corruption and conflicts of interest in those industries. Below are key excerpts of revealing news articles on science corruption from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.
A dull-looking chart projected on the wall of a university office in Jerusalem displayed a revelation that would startle many readers of the Old Testament: The sacred text that people revered in the past was not the same one we study today. An ancient version of one book has an extra phrase. Another appears to have been revised to retroactively insert a prophecy after the events happened. Scholars in this out-of-the-way corner of the Hebrew University campus have been quietly at work for 53 years on one of the most ambitious projects attempted in biblical studies publishing the authoritative edition of the Old Testament, also known as the Hebrew Bible, and tracking every single evolution of the text over centuries and millennia. The ongoing work of the academic detectives of the Bible Project, as their undertaking is known, shows that this text at the root of Judaism, Christianity and Islam was somewhat fluid for long periods of its history, and that its transmission through the ages was messier and more human than most of us imagine. The sheer volume of information makes the Bible Project's version "the most comprehensive critical edition of the Hebrew Bible in existence at the present time," said David Marcus, a Bible scholar at the Jewish Theological Seminary in New York, who is not involved with the project.
It was the kind of study that made doctors around the world sit up and take notice: Two popular high-blood-pressure drugs were found to be much better in combination than either alone. Unfortunately, it wasn't true. Six and a half years later, the prestigious medical journal the Lancet retracted the paper, citing "serious concerns" about the findings. The damage was done. Doctors by then had given the drug combination to well over 100,000 patients. Instead of protecting them from kidney problems, as the study said the drug combo could do, it left them more vulnerable to potentially life-threatening side effects, later studies showed. Today, "tens of thousands" of patients are still on the dual therapy, according to research firm SDI. When a study is retracted, "it can be hard to make its effects go away," says Sheldon Tobe, a kidney-disease specialist at the University of Toronto. And that's more important today than ever because retractions of scientific studies are surging. Since 2001, while the number of papers published in research journals has risen 44%, the number retracted has leapt more than 15-fold, data compiled for The Wall Street Journal by Thomson Reuters reveal. Just 22 retraction notices appeared in 2001, but 139 in 2006 and 339 last year
Note: To learn lots more of how the medical industry puts profit above public health, click here.
It's fraudulent for academics to give their names to medical articles ghostwritten by pharmaceutical industry writers, say two Canadian law professors who call for potential legal sanctions. Studies suggest that industry-driven drug trials and industry-sponsored publications are more likely to downplay a drug's harms and exaggerate a drug's virtues, said Trudo Lemmens, a law professor at the University of Toronto. The integrity of medical research is also harmed by ghostwritten articles, he said. Ghostwriting is part of marketing that can distort the evidence on a drug, Lemmens said. Industry authors are concealed to insert marketing messages and academic experts are recruited as "guest" authors to lend credibility despite not fulfilling criteria for authorship, such as participating in the design of the study, gathering data, analyzing the results and writing up of the findings. Lemmens and his colleague Prof. Simon Stern argue that legal remedies are needed for medical ghostwriting since medical journals, academic institutions and professional disciplinary bodies haven't succeeded in enforcing sanctions against the practice. Ghostwritten publications are used in court to support a manufacturer's arguments about a drug's safety and effectiveness, and academic experts who appear as witnesses for pharmaceutical and medical device companies also boost their credibility with the publications on their CV, Lemmens said.
Note: For a respected doctor's powerful analysis of fraud in the pharmaceutical industry, click here. For lots more from reliable sources on key health issues, click here.
Scientists are in danger of turning animals into monsters unless an ethical watchdog is appointed to prevent Frankenstein-like experiments, the Academy of Medical Sciences has warned. A new report into experiments which transplant human cells into animals for medical purposes said scientists may not be far from giving apes the ability to think and talk like humans. Concerns about the creation of talking apes should be taken seriously along with "what one might call the 'Frankenstein fear' that the medical research which creates 'humanised' animals is going to generate monsters", it was claimed. A regulatory body is needed to closely monitor any experiments that risk creating animals with human-like consciousness, spawning hybrid human-animal embryos, or giving animals any appearance or behavioural traits that too closely resemble humans, the report said. Scientists would, for example, be prevented from replacing a large number of an ape's brain [cells] with human cells as has already been done in simpler animals like mice until much more is known about the potential results.
Note: For more on this in another media article, click here.
Look at the Department of Energy's 2012 budget request for the Livermore Lab and it becomes apparent that PR has an inverse relationship to budget. Some 89 percent of the funds are for nuclear weapons activities. Yet, more than 89 percent of the press releases showcase programs like renewable energy and science that receive less than 3 percent of the spending. This has caused many to believe that Livermore Lab is converting from nuclear weapons to civilian science. A major consequence of the chasm between public perception and where the money actually goes is that science at Livermore continues to exist on the margins - underfunded, understaffed and at the mercy of the 800-pound gorilla of the nuclear weapons budget. Consider the many benefits of transitioning Livermore from nuclear-weapons design to a "green lab," focused on nonpolluting energy development, climate research, basic sciences, nonproliferation and environmental cleanup. Livermore Lab is uniquely qualified to contribute in these areas. The lab already employs the right mix of physicists, other scientists, engineers, materials specialists, and support personnel for these undertakings.
Note: To learn more about how the public is being massively deceived around war and weapons spending, read what a top U.S. general had to say about this at this link.
When doctors are deciding which drug to prescribe a patient, the idea behind evidence-based medicine is that they inform their thinking by consulting scientific literature. To a great extent, this means relying on medical journals. The trouble is that pharmaceutical companies, who stand to win or lose large amounts of money depending on the content of journal articles, have taken a firm grip on what gets written about their drugs. That grip was strong way back in 2004, when The Lancet's chief editor Richard Horton lamented that "journals have devolved into information laundering operations for the pharmaceutical industry." It may be even tighter now. Drug companies exert this hold on knowledge through publication planning agencies, an obscure subsection of the pharmaceutical industry. The planning companies are paid to implement high-impact publication strategies for specific drugs. They target the most influential academics to act as authors, draft the articles, and ensure that these include clearly-defined branding messages and appear in the most prestigious journals. There are now at least 250 different companies engaged in the business of planning clinical publications for the pharmaceutical industry. Many firms are based in the UK and the east coast of the United States. Having talked to over a dozen publication planners I found that the standard approach to article preparation is for planners to work hand-in-glove with drug companies to create a first draft.
Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.
A bizarre spate of television presenters dissolving into on-air gibberish has sparked claims that the U.S. military could be to blame. In four high-profile cases, the latest involving fast-talking Judge Judy, the presenters have started off speaking properly but have then descended into undecipherable nonsense - looking confused and unstable. The frequency of the 'attacks' - and the fact that recorded examples of the mental meltdowns have been popular on websites - has led to conspiracy theorists pointing the finger at shadowy government experiments. A popular theory being circulated online blames the U.S. Militarys supposed research into using microwaves as a mind control weapon. America has never admitted conducting such research but proponents say the effects - produced by microwave signals stimulating the brain with fake images and voices - exactly mimic those displayed in the recent on-air breakdowns. Serene Branson's garbled Grammys report became an internet sensation, while WISCTV's Sarah Carlson suffered a similar meltdown in January. Judith Sheindlin, the fast-talking judge on Judge Judy, was taken to hospital ... after she began speaking a nonsensical string of words during a live recording of her courtroom TV show.
Note: We don't normally use the UK's Daily Mail as a reliable source, but as the video included in this article clearly demonstrate something highly unusual, we've included it here. Another video of this highly strange phemomenon is available here. There is a possibility that some kind of HAARP technologies may be used in doing this. For more, click here. For reliable, verifiable information on secret government mind control programs, see the powerful two-page summary available here.
Shocking as it may seem, U.S. government doctors once thought it was fine to experiment on disabled people and prison inmates. Such experiments included giving hepatitis to mental patients in Connecticut, squirting a pandemic flu virus up the noses of prisoners in Maryland, and injecting cancer cells into chronically ill people at a New York hospital. Much of this horrific history is 40 to 80 years old, but it is the backdrop for a meeting in Washington this week by a presidential bioethics commission. The meeting was triggered by the government's apology last fall for federal doctors infecting prisoners and mental patients in Guatemala with syphilis 65 years ago. U.S. officials also acknowledged there had been dozens of similar experiments in the United States. Inevitably, they will be compared to the well-known Tuskegee syphilis study. In that episode, U.S. health officials tracked 600 black men in Alabama who already had syphilis but didn't give them adequate treatment even after penicillin became available. Though people in the studies were usually described as volunteers, historians and ethicists have questioned how well these people understood what was to be done to them and why, or whether they were coerced. In the last 15 years, two international studies sparked outrage. U.S.-funded doctors failed to give the AIDS drug AZT to all the HIV-infected pregnant women in a study in Uganda even though it would have protected their newborns. The other study, by Pfizer Inc., gave an antibiotic named Trovan to children with meningitis in Nigeria, although there were doubts about its effectiveness. Critics blamed the experiment for the deaths of 11 children and the disabling of scores of others. Pfizer settled a lawsuit with Nigerian officials for $75 million but admitted no wrongdoing.
Note: Though it appears these highly unethical studies have stopped in the US, the article points out that many drug companies are now doing their studies in countries where ethical codes are not strong. For an astounding list of government-sponsored programs where humans were used as guinea pigs, click here. For a two-page summary of solid evidence of government involvement in mind control programs, click here.
Authorities in Japan have begun excavating the former site of a medical school that may contain the remains of victims of the country's wartime biological warfare programme. The school has links to Unit 731, a branch of the imperial Japanese army that conducted lethal experiments on prisoners as part of efforts to develop weapons of mass destruction. The Japanese government has previously acknowledged the unit's existence but refused to discuss its activities, despite testimony from former members and growing documentary evidence. Unit 731, based in Harbin in northern China, conducted experiments on tens of thousands of mostly Chinese and Korean prisoners, and a small number of Allied prisoners of war. Some historians estimate up to 250,000 people were subjected to experiments. According to historical accounts, male and female prisoners, named "logs" by their torturers, were subjected to vivisection without anaesthesia after they had been deliberately infected with diseases such as typhus and cholera. Some had limbs amputated or organs removed. Leading members of the unit were secretly granted immunity from prosecution in return for giving US occupation forces access to years of biological warfare research. Some went on to occupy prestigious positions in the pharmaceutical industry, health ministry and academia.
Note: The US granted immunity to both German and Japanese researchers involved in highly cruel medical experiments which tortured and murdered victims in order to perfect mind control and more. For powerful documentation on this, see our two-page summary available here, and lots more at this link.
If you follow the news about health research, you risk whiplash. First garlic lowers bad cholesterol, thenafter more studyit doesnt. Hormone replacement reduces the risk of heart disease in postmenopausal women, until a huge study finds that it doesnt. But what if wrong answers arent the exception but the rule? More and more scholars who scrutinize health research are now making that claim. It isnt just an individual study here and there thats flawed, they charge. Instead, the very framework of medical investigation may be off-kilter, leading time and again to findings that are at best unproved and at worst dangerously wrong. The result is a system that leads patients and physicians astrayspurring often costly regimens that wont help and may even harm you. Even a cursory glance at medical journals shows that once heralded studies keep falling by the wayside. A major study concluded theres no good evidence that statins (drugs like Lipitor and Crestor) help people with no history of heart disease. The study ... was based on an evaluation of 14 individual trials with 34,272 patients. Cost of statins: more than $20 billion per year. Positive drug trials, which find that a treatment is effective, and negative trials, in which a drug fails, take the same amount of time to conduct. But negative trials took an extra two to four years to be published. With billions of dollars on the line, companies are loath to declare a new drug ineffective. As a result of the lag in publishing negative studies, patients receive a treatment that is actually ineffective. From clinical trials of new drugs to cutting-edge genetics, biomedical research is riddled with incorrect findings.
Note: For the good of your health, the entire article at the link above is well worth reading. For lots more on how the profit-oriented health profession puts public health at risk, click here and here.
Last year, Stanford banned its physicians from giving paid promotional talks for pharmaceutical companies. One thing it didn't do was make sure its faculty followed that rule. A ProPublica investigation ["Dollars for Docs"] found that more than a dozen of the school's doctors were paid speakers in apparent violation of Stanford policy - two of them were paid six figures since last year. Conflict-of-interest policies have become increasingly important as academic medical centers worry that promotional talks undermine the credibility not only of the physicians giving them, but also of the institutions they represent. Yet when it comes to enforcing the policies, universities have allowed permissive interpretations and relied on the honor system. That approach isn't working. Many physicians are in apparent violation, and ignorance or confusion about the rules is widespread. As a result, some faculty physicians stay on the industry lecture circuit, where they can net tens of thousands of dollars in additional income. Critics of the practice say delivering talks for drug companies is incompatible with teaching future generations of physicians. That's because drug firms typically pick the topic of the lecture, train the speakers and require them to use company-provided presentation slides.
Note: "Dollars for Docs" is an ongoing investigation into the influence of drug company marketing payments on medical providers. To search for a doctor in the database, click here.
Few ecological disasters have been as confounding as the massive and devastating die-off of the world's honeybees. The phenomenon of Colony Collapse Disorder (CCD) -- in which disoriented honeybees die far from their hives -- has kept scientists, beekeepers, and regulators desperately seeking the cause. The long list of possible suspects has included pests, viruses, fungi, and also pesticides, particularly so-called neonicotinoids, a class of neurotoxins that kills insects by attacking their nervous systems. For years, their leading manufacturer, Bayer Crop Science, a subsidiary of the German pharmaceutical giant Bayer AG (BAYRY), has tangled with regulators and fended off lawsuits from angry beekeepers who allege that the pesticides have disoriented and ultimately killed their bees. A cheer must have gone up at Bayer on Thursday when a front-page New York Times article, under the headline "Scientists and Soldiers Solve a Bee Mystery," described how a newly released study pinpoints a different cause for the die-off: "a fungus tag-teaming with a virus." The Bayer pesticides, however, go unmentioned. What the Times article did not explore -- nor did the study disclose -- was the relationship between the study's lead author, Montana bee researcher Dr. Jerry Bromenshenk, and Bayer Crop Science. In recent years Bromenshenk has received a significant research grant from Bayer to study bee pollination.
Note: Read the full, revealing article to learn how money often corrupts science. For lots more from reliable sources on corporate corruption, click here.
Can any medical-research studies be trusted? That question has been central to [Dr. John] Ioannidiss career. Hes whats known as a meta-researcher, and hes become one of the worlds foremost experts on the credibility of medical research. He zoomed in on 49 of the most highly regarded research findings in medicine over the previous 13 years, as judged by the science communitys two standard measures: the papers had appeared in the journals most widely cited in research articles, and the 49 articles themselves were the most widely cited articles in these journals. Of the 49 articles, 45 claimed to have uncovered effective interventions. Thirty-four of these claims had been retested, and 14 of these, or 41 percent, had been convincingly shown to be wrong or significantly exaggerated. If between a third and a half of the most acclaimed research in medicine was proving untrustworthy, the scope and impact of the problem were undeniable. Even when the evidence shows that a particular research idea is wrong, if you have thousands of scientists who have invested their careers in it, theyll continue to publish papers on it, he says. Its like an epidemic, in the sense that theyre infected with these wrong ideas, and theyre spreading it to other researchers through journals. Of those 45 super-cited studies that Ioannidis focused on, 11 had never been retested. Perhaps worse, Ioannidis found that even when a research error is outed, it typically persists for years or even decades.
Note: For more along these lines, read the revealing comments of Marcia Angell, former editor-in-chief of the New England Journal of Medicine, on the massive corruption she found in the medical industry. For more, see concise summaries of deeply revealing news articles on corruption in science from reliable major media sources.
Reversing a longstanding policy, the federal government said on [October 29] that human and other genes should not be eligible for patents because they are part of nature. The new position could have a huge impact on medicine and on the biotechnology industry. The new position was declared in a friend-of-the-court brief filed by the Department of Justice ... in a case involving two human genes linked to breast and ovarian cancer. We acknowledge that this conclusion is contrary to the longstanding practice of the Patent and Trademark Office, as well as the practice of the National Institutes of Health and other government agencies that have in the past sought and obtained patents for isolated genomic DNA, the brief said. The issue of gene patents has long been a controversial [one]. Opponents say that genes are products of nature, not inventions, and should be the common heritage of mankind. They say that locking up basic genetic information in patents actually impedes medical progress. Proponents say genes isolated from the body are chemicals that are different from those found in the body and therefore are eligible for patents. In its brief, the government said it now believed that the mere isolation of a gene, without further alteration or manipulation, does not change its nature.
Note: This is great news. To see how patents have been used in scary ways to promote global monopolies, watch this documentary.
Many drug trials involve a placebo, a sham drug whose results are compared with the results of the real medication. A placebo is supposed to contain a harmless substance, such as sugar or vegetable oil, which has no significant effect on the body. In [a new] study, researchers delved into 176 studies published in reputable medical journals ... from January 2008 to December 2009 to see if placebo contents were disclosed and if so, what they were. The study authors argue that placebo ingredients may not always be as inconsequential as some may think. They write: "For instance, olive oil and corn oil have been used as the placebo in trials of cholesterol-lowering drugs. This may lead to an understatement of drug benefit: The monounsaturated and polyunsaturated fatty acids of these 'placebos,' and their antioxidant and anti-inflammatory effects, can reduce lipid levels and heart disease." Certain placebos, they add, may skew results in favor of the active drug. The researchers referenced a trial for a drug used to treat anorexia linked with cancer in which a lactose placebo was used. Since lactose intolerance is common among cancer patients, the fact that some suffered stomach problems from the placebo may have made the actual drug look more beneficial. "Perfect placebo is not the aim," they write, "rather, we seek to ensure that its composition is disclosed."
Note: For key reports from major media sources on important issues related to health and medicine, click here.
Research universities that accept millions of dollars from oil companies have failed to shield themselves from corporate influence, according to a new study that faults UC Berkeley, UC Davis, Stanford and seven others. Such cozy relationships give energy companies too much control in deciding what research to fund and what faculty should study, says the report from the Center for American Progress, "Big Oil Goes to College". The contracts ... give more control to companies that foot the bill than to researchers, argues the report's author, Jennifer Washburn. "We want to see university research translate into commercial technology, but we don't want the research itself to be directed by individual corporations," she told The Chronicle. "They shouldn't turn California's flagship universities into the research arm of a private corporation." The report found that industry control over research is "poorly defined" in UC Davis' long-term contract with Chevron Technology Ventures. It says industry shares control with faculty at UC Berkeley, and control is fully corporate at Stanford. The report also says none of the three California contracts "requires peer review when selecting faculty research projects."
Note: For lots more from major media sources on corporate corruption, click here.
If you want to understand the way prescription drugs are marketed today, have a look at the 1928 book, Propaganda, by Edward Bernays, the father of public relations in America. For Bernays, the public relations business was less about selling things than about creating the conditions for things to sell themselves. When Bernays was working as a salesman for Mozart pianos, for example, he did not simply place advertisements for pianos in newspapers. That would have been too obvious. Instead, Bernays persuaded reporters to write about a new trend: Sophisticated people were putting aside a special room in the home for playing music. Once a person had a music room, Bernays believed, he would naturally think of buying a piano. As Bernays wrote, "It will come to him as his own idea." Just as Bernays sold pianos by selling the music room, pharmaceutical marketers now sell drugs by selling the diseases that they treat. The buzzword is "disease branding." To brand a disease is to shape its public perception in order to make it more palatable to potential patients. Once a branded disease has achieved a degree of cultural legitimacy, there is no need to convince anyone that a drug to treat it is necessary. It will come to him as his own idea. It is hard to brand a disease without the help of physicians, of course. So drug companies typically recruit academic "thought leaders" to write and speak about any new conditions they are trying to introduce.
Note: This key topic is discussed in great depth in the BBC's documentary "Century of the Self" available here. And for a top doctor's analysis that the cholesterol scare was largely manufactured for profit, click here.
The astounding revelation that U.S. medical researchers intentionally gave Guatemalans gonorrhea and syphilis more than 60 years ago is so horrifying that we want to believe that what happened then could never happen today. A report from the United States Department of Health and Human Services noted that roughly 80 percent of drug approvals in 2008 were based in part on data from outside the U.S. Susan Reverby, a distinguished historian at Wellesley College in Massachusetts, has ... long researched the infamous Tuskegee Syphilis Study, the experiment where poor, black men in rural Alabama were deliberately left untreated for syphilis by government researchers. The study, somehow, was allowed to run from 1932 to 1972. More recently, Reverby came across documents that showed that Dr. John C. Cutler, a physician who would later be one of the researchers involved in the Tuskegee study, was involved in a completely unethical research study much earlier in Guatemala. Cutler, who went to his grave defending the Tuskegee experiment, directly inoculated unknowing prisoners in Guatemala with syphilis and also encouraged them to have sex with diseased prostitutes for his research from 1946-48. His work was sponsored by lauded organizations such as the United States Public Health Service, the National Institutes of Health with collaboration of the Pan American Health Sanitary Bureau (now the Pan American Health Organization), and the Guatemalan government.
Note: The author of this commentary is Arthur Caplan, director of the Center for Bioethics at the University of Pennsylvania. For many other examples of government-sponsored experimentation on human guinea pigs, click here.
The United States apologized Friday for a 1946-1948 research study in which people in Guatemala were intentionally infected with sexually transmitted diseases. A statement by Secretary of State Hillary Clinton and Secretary of Health and Human Services Secretary Kathleen Sebelius called the action "reprehensible." President Barack Obama called his Guatemalan counterpart Friday "offering profound apologies and asking pardon for the deeds of the 1940s," President Alvaro Colom told CNN. "Though it happened 64 years ago, it really is a profound violation of human rights," said Colom. The U.S. Public Health Service Sexually Transmitted Disease Inoculation Study of 1946-1948 aimed at determining the effectiveness of penicillin in treating or preventing syphilis after subjects were exposed to the disease. Gonorrhea and chancres were also studied. The tests were carried out on female commercial sex workers, prisoners in the national penitentiary, patients in the national mental hospital and soldiers. According to the study, more than 1,600 people were infected: 696 with syphilis, 772 with gonorrhea and 142 with chancres. The published literature contains more than 40 other U.S.-based studies "where intentional infection was carried out with what we could now consider to be completely inadequate consent in the United States." Many of those studies were funded by the Public Health Service.
Note: Read about the long history of humans being used as guinea pigs in unethical experiments. For more along these lines, see concise summaries of deeply revealing news articles on government corruption from reliable major media sources.
Nearly two years ago, a study known as the JUPITER [Justification for the Use of Statins in Primary Prevention] trial hinted at a new era in the use of statins -- one in which the cholesterol-busting drugs could be used to stave off heart-related death in many more people than just those with high cholesterol. Now, however, researchers behind a new review that takes a second look at the findings of the landmark study say that these results are flawed -- and that they do not support the benefits initially reported. Not only did this second look turn up no evidence of the "striking decrease in coronary heart disease complications" reported by investigators behind JUPITER, but it has also called into question drug companies' involvement in such trials, according to an article in the June 28 issue of Archives of Internal Medicine. Moreover, Dr. Michel de Lorgeril of Joseph Fourier University and the National Center of Scientific Research in Grenoble, France, and coauthors argue that major discrepancies exists between the significant reductions in nonfatal stroke and heart attacks reported in the JUPITER trial and what has been found in other research. "The JUPITER data set appears biased," Lorgeril and coauthors wrote in conclusion. De Lorgeril and coauthors point out that nine of 14 authors of the JUPITER article have financial relationships with AstraZeneca, which sponsored the trial.
Note: There is intriguing evidence that much of the fear around cholesterol was fabricated to sell drugs. For more on this, see the article by one of the most respected doctors on the Internet at this link.
Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
